{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"A Health Podyssey","title":"What Most Favored Nation Drug Pricing Would Mean for the US","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/364cdcdb\"></iframe>","width":"100%","height":180,"duration":1435,"description":"Health Affairs' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing, weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs.","thumbnail_url":"https://img.transistorcdn.com/RneDq6FP97HYBXbb6ygZjKJa8RJU_wIDSHFVqnbfKe8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE0ODU4LzE2MDE0/MDI1NzEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}